ASHLEY WRIGHT: Open Payments
NPI 1083155006 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 85 payments from 32 companies in 2025. Trend: 2023 $1,788 · 2024 $1,926 · 2025 $1,874
Food & beverage: $1,755Education: $119
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $225 |
| Exelixis Inc. | 4 | $167 |
| Merck Sharp & Dohme LLC | 7 | $148 |
| E.R. Squibb & Sons, L.L.C. | 9 | $145 |
| Janssen Biotech, Inc. | 5 | $136 |
| ABBVIE INC. | 4 | $101 |
| Daiichi Sankyo Inc. | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Lilly USA, LLC | 3 | $60 |
Products named: KEYTRUDA, OPDIVO, RYBREVANT, CALQUENCE, Enhertu, EPKINLY, CABOMETYX, IMFINZI.
Industry payments across AL — which companies pay providers there.
